Completed

Evaluation of Patients With Known or Suspected Heart Disease

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Peripheral Artery Disease
+4

+ Coronary Disease
+ Diabetes and Heart Failure
How is the trial designed

Other

Observational
Study Start: May 1992

Summary

Principal SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner
Study start date: May 10, 1992Actual date on which the first participant was enrolled.

In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test. These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies. The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.

Official TitleEvaluation of Patients With Known or Suspected Heart Disease (Screening Protocol) 
Principal SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Peripheral Artery Disease
Coronary Disease
Diabetes and Heart Failure
Dilated Cardiomyopathy
Heart Failure
Renal Artery Stenosis
Pulmonary Hypertension
Criteria

* INCLUSION CRITERIA: The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: 1. Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing. 2. Cardiomyopathies including congestive phenotypes. 3. Peripheral artery disease with intermittent claudication or limb-threatening ischemia. 4. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. 5. Upper extremity peripheral artery disease. 6. Diabetes with heart failure. 7. Pulmonary hypertension. EXCLUSION CRITERIA: Pregnancy, for those patients who require catheterization-based diagnostics. Inability to provide informed consent.



Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 2 locations
Suspended
Suburban HospitalBethesda, United StatesSee the location
Suspended
National Institutes of Health Clinical Center, 9000 Rockville PikeBethesda, United States

Completed2 Study Centers